Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
179,930,016
-
Share change
-
+4,043,371
-
Total reported value
-
$22,185,209,979
-
Put/Call ratio
-
79%
-
Price per share
-
$123.34
-
Number of holders
-
507
-
Value change
-
+$736,875,977
-
Number of buys
-
280
-
Number of sells
-
206
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2020
As of 30 Jun 2020,
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) was held by
507 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
179,930,016 shares.
The largest 10 holders included
Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, Clearbridge Investments, LLC, STATE STREET CORP, Dodge & Cox, and AMERIPRISE FINANCIAL INC.
This page lists
513
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.